TherapeuticsMD (TXMD) Revenue (2011 - 2026)

TherapeuticsMD has reported Revenue for 16 years, with the latest figure at $724000.0 in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 84.22% year-over-year to $724000.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (up 82.13% YoY), and the FY2025 full-year result was $3.0 million, up 71.61% from the prior year.
• Revenue for Q1 2026 stood at $724000.0, down from $893000.0 in the prior quarter.
• The five-year high for Revenue was $68.6 million in Q4 2022, with the low at $53000.0 in Q3 2023.
• Historically, Revenue has averaged $4.5 million across 5 years, with a median of $502000.0 in 2023.
• Annual changes were most pronounced in 2023 — Revenue slumped 99.27% — and 2024, when it soared 932.08%.
• TherapeuticsMD's Revenue stood at $68.6 million in 2022, then tumbled by 99.27% to $502000.0 in 2023, then soared by 32.87% to $667000.0 in 2024, then soared by 33.88% to $893000.0 in 2025, then slipped by 18.92% to $724000.0 in 2026.
• The last three Revenue figures came in at $724000.0 (Q1 2026), $893000.0 (Q4 2025), and $784000.0 (Q3 2025), per Business Quant data.